Wedmont Private Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.53M | Buy |
5,284
+929
| +21% | +$445K | 0.11% | 114 |
|
|
2025
Q1 | $2.11M | Buy |
4,355
+722
| +20% | +$350K | 0.11% | 113 |
|
|
2024
Q4 | $1.49M | Buy |
3,633
+384
| +12% | +$157K | 0.08% | 152 |
|
|
2024
Q3 | $1.46M | Buy |
3,249
+65
| +2% | +$29.2K | 0.08% | 147 |
|
|
2024
Q2 | $1.56M | Buy |
3,184
+126
| +4% | +$61.6K | 0.1% | 125 |
|
|
2024
Q1 | $1.24M | Buy |
3,058
+213
| +7% | +$86.2K | 0.09% | 145 |
|
|
2023
Q4 | $1.19M | Buy |
2,845
+342
| +14% | +$143K | 0.1% | 135 |
|
|
2023
Q3 | $889K | Buy |
2,503
+235
| +10% | +$83.5K | 0.09% | 144 |
|
|
2023
Q2 | $800K | Buy |
2,268
+489
| +27% | +$172K | 0.09% | 157 |
|
|
2023
Q1 | $575K | Sell |
1,779
-131
| -7% | -$42.3K | 0.08% | 196 |
|
|
2022
Q4 | $554K | Buy |
1,910
+308
| +19% | +$89.4K | 0.08% | 187 |
|
|
2022
Q3 | $464K | Buy |
1,602
+330
| +26% | +$95.6K | 0.09% | 172 |
|
|
2022
Q2 | $358K | Buy |
1,272
+310
| +32% | +$87.2K | 0.08% | 195 |
|
|
2022
Q1 | $258K | Buy |
+962
| New | +$258K | 0.06% | 260 |
|